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The Trade-Off between Costs and
Outcomes: The Case of Acute
Myocardial Infarction
Jonas Schreyo ¨gg and Tom Stargardt
Objective. To investigate and to quantify the relationship between hospital costs and
healthoutcomesforpatientswithacutemyocardialinfarction(AMI)inVeteransHealth
Administration (VHA) hospitals using individual-level data for costs and outcomes.
Data Sources. VHA administrative ﬁles for the ﬁscal years 2000–2006.
Study Design. Costs were deﬁned as costs incurred during the index hospitalization for
treatment of AMI. Mortality and readmission, assessed 1 year after the index hospital-
ization, were used as measures of clinical outcome. We examined health outcomes as a
functionofcostsandotherpatient-levelandhospital-levelcharacteristicsusingatwo-stage
Cox proportional hazard model that accounted for competing risks within a multilevel
framework. To control for patient comorbidities, we compiled a comprehensive list of
comorbidities that have been found in other studies to affect mortality and readmissions.
Principal Findings. We found that costs were negatively associated with mortality
and readmissions. Every U.S.$100 less spent is associated with a 0.63 percent increase
in the hazard of dying and a 1.24 percent increase in the hazard to be readmitted
conditional on not dying. This main ﬁnding remained unchanged after a number of
sensitivity checks.
Conclusions. Our results suggest that there is a trade-off between costs and outcomes.
The negative association between costs and mortality suggests that outcomes should be
monitoredclosely whenintroducingcost-containment programs.Additionalstudies are
needed to examine the cost–outcome relationship for conditions other than AMI to see
whether our results are consistent.
Key Words. Hospital costs, acute myocardial infarction, trade-off, outcomes, read-
mission, mortality
Providing high-quality health care services at reasonable costs is the central
policy goal in most health care systems. Because of rising health expenditures
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Health Services Researchin many industrialized countries, a variety of cost-containment measures have
been introduced in recent years, including DRGs and diverse managed care
instruments. This has led to mounting pressures on hospitals to reduce costs
but also to increasing public concerns that these pressures may result in wors-
ened health outcomes.
Previous studies exploring the relationship between hospital costs and
health outcomes have reported conﬂicting results (Fleming 1991; Carey and
Burgess 1999; Mukamel, Zwanziger, and Tomaszewski 2001). Most of these
studieswereconducted atthe hospitallevelusingaggregatemeasuresforcosts
and outcomes. Although this method has certain advantages from a policy
perspective, it precludes adequate control for case mix. Our study takes a
different approach by focusing on acute myocardial infarction (AMI) as one
episode of care. AMI has several important advantages when it comes to
investigatingtherelationshipbetweencostsandoutcomes.First,becauseAMI
requires immediate medical attention, patient selection between hospitals is
less relevant than for other conditions. Second, the incidence of AMI is high,
and it is the leading cause of death in the elderly, resulting in a substantial
number of hospital cases. Third, hospitals that provide higher quality care can
achieve substantially lower mortality rates (McClellan and Staiger 2000; Shen
2002; Landrum et al. 2004).
To overcome problems associated with aggregate measures, we used
patient-level measures for costs, outcomes, and comorbidity. Because of the
fragmentation of health care systems, patient-level data usually provide in-
formation from either (a) the payer perspective (e.g., Medicare), which in-
cludes information on posthospitalization outcomes, but not on actual costs
per patient, or (b) the hospital perspective, which includes actual costs per
patient, but no information on posthospitalization outcomes. With this in
mind,theintegratedhealthcaresystemoftheVeteransHealthAdministration
(VHA) is well suited to capturing both perspectives. In addition, patient-level
datafrom the VHA databases permita relatively high level ofconsistency. VHA
hospitals have been subject to budgetary pressures similar to those experienced
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ing measure applied in VHA hospitals (Yaisawarng and Burgess 2006).
In this paper, we investigate the relationship between hospital costs
and health outcomes for patients with AMI at index hospitalization in VHA
hospitals.Todoso,weusedmortalityandreadmissionfollowingAMIfor1year
at index hospitalization as health-outcome measures. We examined health out-
comes as a function of costs and other patient-level and hospital-level deter-
minants of outcome usingrandom-effects Cox proportional hazard models.We
also accounted for competing risk between mortality and readmission.
The paper is structured as follows: the next (i.e., second) section reviews
the relevant literature on the relationship between hospital costs and health
outcomes. The following section presents the methodology used in this paper
toexplorethisrelationship.Thenexttwosectionsdescribethedatausedinthe
analysis and the estimated results, respectively. The ﬁnal section discusses the
implications of the results and makes several suggestions for future research.
PREVIOUS RESEARCH
Previous studies examining the relationship between hospital costs and health
outcomes have reached divergent conclusions. Whereas some studies have
found a positive association between hospital costs and health outcomes
(Mukamel, Zwanziger, and Tomaszewski 2001), others have concluded that
low hospital costs and excellent health outcomes are not mutually exclusive
(Fleming 1991; Carey and Burgess 1999). Weech-Maldonado, Shea, and Mor
(2006) examined the cost/outcome relationship for nursing homes and found
that the pattern of the relationship depended on the choice of outcome mea-
sures. Different studies examining the relationship between inefﬁciency and
health outcomes have also yielded contradictory results. Morey et al. (1992)
and Deily and McKay (2006) found that a hospital’s inefﬁciency score was
positively associated with the observed in-hospital mortality rate, whereas
McKay and Deily (2008) did not ﬁnd any consistent association.
There are generally two ways of approaching the cost/outcome rela-
tionship. Some studies have used cost functions with costs as the dependent
variable, where outcome measures were explanatory variables in a given cost
function (Fleming 1991; Carey and Burgess 1999; Weech-Maldonado, Shea,
and Mor 2006). This cost function usually has a hybrid functional form fol-
lowing Grannemann, Brown, and Pauly (1986). However, Mukamel,
Zwanziger, and Tomaszewski (2001), Deily and McKay (2006), and McKay
The Trade-Off between Costs and Outcomes 1587and Deily (2008) used outcomes as the dependent variables, where hospital
cost was one explanatory variable.
A common feature of these studies is their use of aggregate measures for
costs and health outcomes. Most studies use mortality (i.e., usually in-hospital
mortality) as the only outcome measure (Morey et al. 1992; Mukamel,
Zwanziger, and Tomaszewski 2001; Deily and McKay 2006). Using both
readmissions and mortality, Fleming (1991) found that the association with
costs was positive at low outcome levels, negative at intermediate outcome
levels, and positive again at high outcome levels for both outcomes measures.
However, McKay and Deily (2008) also used readmissions in addition to
mortality and found no systematic pattern. Carey and Burgess (1999) used
posthospitalization outcomes for mortality and readmission, as well as out-
patient follow-up rates. They found that all three outcome measures were
positively associated with hospital costs (i.e., high levels of mortality were
associated with high costs). Weech-Maldonado, Shea, and Mor (2006) used
pressure ulcers and mood decline as outcome measures in nursing homes.
METHODOLOGY
Empirical Model
The goal of the present study was to explore and to quantify the relationship
between costs and outcomes of treatment for AMI while controlling for co-
morbidity, input quality, and organizational hospital characteristics. We used
individual-level data for costs, outcomes, and comorbidity from the VHA.
Costs were deﬁned as costs incurred during the index hospitalization for
treatment of AMI. Mortality and readmission, each assessed 1 year after the
index hospitalization, were used as measures of clinical outcome.
We hypothesized that outcomewouldbea function of age, comorbidities,
costs, and hospital organizational characteristics. While age, comorbidities, and
costs can differ for each treated patient, hospital organizational characteristics
remain identical for all patients treated in a given hospital. As a result, obser-
vations across patients violate assumptions such as independence and common
variance. Signiﬁcance tests are thus not robust and would overestimate the
precision of information provided by the hospital-level variables. To avoid this
problem,weappliedrandom-effectsproportionalhazardmodels,alsoknownas
frailty models (Yamaguchi et al. 2002; Glidden and Vittinghoff 2004).
In our study, we took a two-level multilevel modeling approach, nesting
treatedpatientsasmicrounitswithinhospitals,whichwere,inturn,considered
1588 HSR: Health Services Research 45:6, Part I (December 2010)to be macrounits. We used the following model:
hijðtÞ¼h0ðtÞ expðbXij þ gZj þ l0jÞ
¼ x0j   h0ðtÞ expðbXij þ gZjÞ
where hij(t) is the hazard for the ith patient in the jth hospital at time t. h0(t)i s
the unspeciﬁed baseline hazard. Xij is a vector of explanatory variables at the
patient level, while Zj is a vector of explanatory variables at the hospital
level. b and g are two vectors that measure the effects of Xij and Zj, respec-
tively. l0j,o rx0j (5exp(l0j)), if interpreted as a factor, represent the deviation
ofhospitaljfromtheoverallbaselinehazard.lj0isassumedtofollowanormal
distribution.
Twomodelswereestimated,onemodelfortimetodeathandonemodel
for time to readmission. As the event ‘‘death’’ is a competing risk for the event
‘‘readmission,’’ that is, death at a speciﬁc point in time thereafter excludes
readmission,wetreatedobservationsthatdiedascensoredatthetimeofdeath
in the readmission model (Allison 2005; Sa ´, Dismuke, and Guimaras 2007).
The event of ‘‘readmission,’’ however, is not a competing risk for the event
‘‘death’’ becausethedataallowed afollow-upfor365days after index admission.
We also assumed that costs were endogenous to health outcomes, which
we conﬁrmed using the Hausman test (Hausman 1978). Thus, we subse-
quently used two-stage residual inclusion (2SRI) based on Terza, Basu, and
Rathouz (2008). The two-stage approach is less efﬁcient than full information
maximum likelihood but yields consistent estimates. 2SRI has been used be-
foreforsurvivaloutcomesinahealthcarecontextbyLindroothandWeisbrod
(2007).Themethodrequirestheuseofinstrumentalvariables,thatis,variables
that are highly correlated with the endogenous variable (costs), but not with
unobserved determinants of the main outcome variable of interest (time to
readmission conditional on not dying, time to death). These assumptions are
often satisﬁed by variables that are correlated with the endogenous variable
but have no direct effect on the outcome variable (Cameron and Trivedi
2005). We believe that the Medicare Wage Index and general overhead costs
per day at the hospital level meet these criteria. The Medicare Wage Index
adjusts hospital costs for regional differences in medical wages across the
United States. One could argue that higher wages may represent an extrinsic
incentive for staff to perform better and deliver higher quality care. However,
the Medicare Wage Index only covers wage differences between, and not
within, regions and thus is unlikely to have a direct effect on health outcomes.
General overhead costs per day at the hospital level include cost elements
The Trade-Off between Costs and Outcomes 1589from the nonmedical infrastructure of a hospital, for example, costs for activ-
ities such as housekeeping, engineering, and administration. Note that we
excluded medical department overhead from overhead costs. The variable
‘‘General overhead costs per day’’ thus acts as a proxy for the price level
a hospital faces to purchase certain activities excluding prices for medical
personnel. The costs are allocated by charging the same amount for each
patientdayirrespectiveofthereasonforadmission.Thus,thisisaspeciﬁctype
of overhead costs, which does not relate to the actual hospital stay of each
patient. These overhead costs are predominantly ﬁxed in the short term and
are not related to AMI treatment and severity of disease. It should also be
pointed out that this type of overhead costs is not related to either hospital size
or angiography, because we control for both of these in the analysis at both
stagesoftheestimation.Givenourdeﬁnitionofgeneraloverheadcostsperday
atthehospitallevel,thevariableishighlycorrelatedwithindividuallevelcosts
per case but is unlikely to be associated with health outcomes.
Several other variables may have been theoretically suitable as instru-
ments. In particular we also included the hospital’s occupancy rate and the
overall hospital’s case mix. However, their explanatory power was calculated
to be low (i.e., with an F-value o10). Because the use of weak instruments can
be problematic in statistical analysis, we ultimately decided to use only two
instruments (Bartels 1991).
Estimation Issues
We ﬁrst estimated a generalized linear mixed model with cost as the dependent
variable and all variables at the patient and hospital levels, including the Med-
icare Wage Index and general overhead costs per day at the hospital level, as
explanatoryvariables.Weassumedagammadistributionforthevariable‘‘cost’’
and used a log-link function. The gamma procedure of the mgcv package of R
wasused.Thefunctionalformofthecostfunctionincorporatesvariablesusedin
structuralcostfunctionsandvariablesonanadhocbasis(Grannemann,Brown,
andPauly1986).Wedroppedexplanatoryvariablesincasesofmulticolinearity.
Subsequently, we estimated two separate random-effects proportional
hazardmodelsformortalityandreadmission usingthesurvival packageofthe
statistical program R, which allows for frailty models. Actual costs and resid-
uals from the ﬁrst-stage regression were used in the second stage (Terza, Basu,
and Rathouz 2008). We also reestimated including polynomials of the resid-
uals. To adjust standard errors of the second-stage regression for including
estimated residuals from the ﬁrst stage, Murphy–Topel adjustment was used
1590 HSR: Health Services Research 45:6, Part I (December 2010)(Murphy and Topel 1985). To assess the validity of the proportional hazards
assumption, we plotted scaled Schoenfeld residuals against event time. In
addition, according to a test suggested by Grambsch and Therneau (1994), we
regressed scaled Schoenfeld residuals on event time for each covariate and
tested for zero slope.
DATA
Theprimary data sourcein thisstudywasa set of VHAadministrativeﬁlesfor
the ﬁscal years 2000 through 2006. For each AMI patient, we selected the
index hospitalization during which a primary diagnosis of AMI was made.
Readmission and mortality were assessed 1 year after discharge from the
index hospitalization. We excluded all patients who were admitted and dis-
charged on the same day, because we assumed that these patients were trans-
ferredtootherhospitalsorruledoutforAMI.Moreover,weexcludedpatients
who had been admitted with AMI in the previous year, as well as those whose
AMIwascodedasanin-hospitalcomplication.Ultimately,atotalof115VHA
hospitals with 35,279 patients remained in the sample.
For measuring costs, the VHA database offers several advantages over
the American Hospital Association data commonly used in U.S. hospital cost
estimation, because the former is based on the requirement that hospitals
provide information to a standardized internal accounting system that is sub-
ject to extensive periodic audits.The VHA accountingsystem wasestablished
in the 1990s and has been continuously improved since then. It provides
detailedcostinformationforhospitalizationepisodesandthusindividual-level
cost data. Moreover, it includesthecostsof physicians while,at the same time,
excluding capital costs. We eliminated the costs of postacute care, a compo-
nent usually included in VHA hospital costs, from the total costs, and we
excluded patients whose total treatment costs were recorded as being
oU.S.$100, interpreting this as an obvious accounting error. Finally, costs
were deﬂated to reﬂect year 1999 values.
To control for patient comorbidities, we compiled a comprehensive list
of comorbidities that have been found in other studies to affect mortality. In
doing so, we relied on the Ontario Acute Myocardial Infarction Mortality
Prediction Rules (Tu et al. 2001) and the Charlson Comorbidity Index (Sun-
dararajan et al. 2004). Because Evans et al. (2007) have shown that comor-
bidities associated with mortality in AMI patients are also associated with
resource use, we hypothesized thatthese and other predictors of mortalityrisk
The Trade-Off between Costs and Outcomes 1591wouldalsobeassociatedwithinpatientcosts.Wethusalsoincludedthefullset
of comorbidities for the ﬁrst-stage cost estimation. For coding diagnoses, the
VHA uses ICD-9 codes.
We obtained data on hospital organizational characteristics that we
judged to be potentially associated with outcomes. The number of treated
AMI patients per hospital was included to control for volume effects, because
a larger number of treated cases has been found to be associated with superior
outcomes for speciﬁc indications (Birkmeyer et al. 2002). Following an ap-
proachtakeninpreviousstudies,weusedthenumberofbedstocontrolforthe
size of the hospital (Carey and Burgess 1999; Dudley et al. 2000).
We also included variables for hospital characteristics to control for
input quality. One of these was a dummy variable for a hospital’s teaching
status, which we used as a proxy for staff qualiﬁcation and equipment. Each
VHA hospital wasclassiﬁedas a teaching-afﬁliatedhospital if it wasa member
of the Council of Teaching Hospitals (COTH). As a proxy for labor intensity,
we included the ratio of nurses per bed for each hospital (Needleman et al.
2002; Kovner et al. 2002). For the nursing ratio, full-time equivalents were
calculated. Following Landrum et al. (2004), we also included a dummy vari-
able for a hospital’s capability to perform coronary angiography; we counted
ﬁve or more claims for coronary angiography as evidence of a hospital’s
capability to perform this procedure. All hospital characteristics were also
included in the ﬁrst-stage cost equation. To control for regional effects, we
included regional dummies into ﬁrst- and second-stage equations.
As discussed previously, we estimated a cost equation in the ﬁrst stage.
The additional variables included in this equation are the Medicare Wage
Index obtained from the Centers for Medicare and Medicaid Services and
general overhead costs per day on hospital level. Finally, we controlled for
years in each equation.
RESULTS
Table 1 shows the sample characteristics for all variables. Table 2 presents
coefﬁcient estimates and p-values for the ﬁrst-stage cost equation. The signs of
theestimatedcoefﬁcients weregenerallyinlinewithourexpectations,andthe
variables for Medicare Wage Index and general overhead costs per day were
highly signiﬁcant.
Table 3 shows the results of the second-stage regression models, with
mortality and readmission conditional on not dying as dependent variables.
1592 HSR: Health Services Research 45:6, Part I (December 2010)Table1: Characteristics of the Study Sample
Mean SD
Costs (U.S.$) 8,035 9,553
Length of stay (days) 7.89 8.17
Medicare Wage Index 26.12 4.09
Overhead per day (U.S.$) 513 246
Hospital characteristics
AMI cases (no.) 72.8 39.4
COTH (%) 49.1
Beds (no.) 175.5 87.5
Nursing ratio per bed (no.) 2.7 0.7
Angiography capability (%) 86.1
Outcome variables (%)
Mortality 30 daysn 1.1
Mortality 60 daysn 1.7
Mortality 90 daysn 2.2
Mortality 365 daysn 3.5
Readmission 30 days 2.7
Readmission 60 days 3.7
Readmission 90 days 4.4
Readmission 365 days 6.8
Age and comorbidities
Age 65.2 11.4
Gender (%) (5female) 1.7
Acute renal failure (%) 2.1
Angina pectoris (%) 1.9
Cancer (%) 3.8
Cardiac dysrhythmias (%) 8.6
Cerebrovascular disease (%) 2.4
Chronic ischemic heart disease (%) 67.3
Chronic renal failure (%) 7.1
Congestive heart failure (%) 6.6
Diabetes (%) 24.6
Diabetes complications (%) 3.4
Hypertensive heart disease (%) 0.4
Liver (%) 0.1
Peripheral vascular disease (%) 3.8
Pulmonary disease (%) 16.1
Shock (%) 0.4
Region (%)
Northeast 20.4
Southeast 37.7
Central 30.5
West coast 11.4
nValues for mortality do not include cases who died during index hospitalization.
AMI, acute myocardial infarction; COTH Council of Teaching Hospitals.
The Trade-Off between Costs and Outcomes 1593For the mortality equation, the majority of coefﬁcients had the expected signs
and the equation showed a highly signiﬁcant negative association between
costsandmortality.EveryU.S.$100lessspentisassociatedwitha0.63percent
increase in the hazard of dying. The risk for mortality also decreased signiﬁ-
cantly as the number of treated AMI cases per hospital increased (each ad-
ditional AMI case treated decreased the hazard of dying by 0.32 percent).
Other hospital-level variables were not signiﬁcant. The readmission equation
also yielded expected results for most coefﬁcients. Costs are, again, negatively
associated with readmission conditional on not dying. Every U.S.$100 less
spent is associated with a 1.24 percent increase in the hazard to be readmitted
conditional on not dying. Except for angiographic capability that was pos-
itively associated with readmission conditional on not dying, hospital-level
variables were not signiﬁcant. Regional ﬁxed effects were not signiﬁcant in
both equations.
Table2: Results of the First-Stage Cost Equation
Variable Coefﬁcient SD p-Value
Intercept 2.7182 0.1815 o.0001
Overhead per day 0.0006 0.00007 o.0001
Medicare Wage Index 0.0318 0.0059 o.0001
Hospital characteristics
AMI cases 0.1007 0.0681 .1395
COTH 0.0357 0.0435 .4120
Beds 0.0067 0.0353 .8493
Nursing ratio per bed  0.0297 0.0292 .3098
Angiography capability 0.1631 0.0458 .0004
Years (20065reference year)
Year 1999  0.1966 0.0356 o.0001
Year 2000  0.1895 0.0253 o.0001
Year 2001  0.1335 0.0253 o.0001
Year 2002  0.0708 0.0245 .0039
Year 2003  0.0193 0.0248 .4368
Year 2004 0.0126 0.0249 .6147
Year 2005 0.0282 0.0253 .2645
Regions (central5reference region)
Northeast 0.0982 0.0471 .0372
Southeast 0.0759 0.0463 .1010
West coast 0.0687 0.0634 .2781
Comorbidities, age, and gender Included
Note. The dependent variable is costs in U.S.$100 per index hospitalization with AMI. The
coefﬁcients for AMI cases (no.) and beds were multiplied by 100.
AMI, acute myocardial infarction; COTH Council of Teaching Hospitals.
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The Trade-Off between Costs and Outcomes 1595We tested the robustness of our ﬁndings in ﬁve ways. To begin with, we
reestimated the ﬁrst- and second-stage regressions using readmission and
mortality assessed 1 year after admission from the index hospitalization in-
stead of discharge. Thus, in these reestimated models mortality and readmis-
sionaredatedfromtheadmissiontothehospital because onecould arguethat
if dated from discharge some individuals would be observed shorter than
othersduetolongerhospitalization.Thecoefﬁcientsforcostsremainedalmost
throughout the reestimated equations and were highly signiﬁcant. Second, we
ran the models by excluding cases that were transferred between different
hospitals during index hospitalization (3,131 cases). The modiﬁcation had
verylittleimpactonthecoefﬁcientofthecostvariable,whichremainedhighly
signiﬁcant in both equations. Third, we reestimated both models without a
multilevelapproachdroppingthehigherlevelvariables.Indoingso,wemade
a correction for clusters of the variance–covariance matrix to obtain a robust
estimate in the second stage. The size of the coefﬁcients decreased slightly in
both equations, but it remained highly signiﬁcant. Fourth, we ran the models
with an extended observation period of 2 years instead of 1 year for both
outcomes. Again the modiﬁcation had very little impact on the coefﬁcient of
the cost variable, which remained highly signiﬁcant in both equations. Fifth,
we obtained F-statistics to test the reliability of our instrument (i.e., whether
our instrument was correlated with the costs). Because the F-statistics for the
Medicare Wage Index and general overhead per day were 23.69 and 58.91,
respectively,weak correlation isunlikelytobeasourceofbias(Bound,Jaeger,
and Baker 1995; Staiger and Stock 1994).
When plotting scaled Schoenfeld residuals against event time for the
survival models, the mortality model appeared to be a good ﬁt to the data.
Accordingtotheregressions,theproportionalassumptionseemstohavebeen
violated for the variable ‘‘Chronic renal failure,’’ and some of the dummy
variables for year of treatment. However, this might also be due to the OLS
regression being heavily inﬂuenced by outliers (Thompson et al. 2003) that
could be identiﬁed in the plots. In the readmission model, however, the pro-
portional hazard assumption seems to have been violated more often. There-
fore, and as an additional sensitivity analysis, we also ﬁtted a Weibull model
formortalityandreadmission,respectively.Theresultsinbothmodels,thatis,
the sign of the coefﬁcient for the variable cost and the p-value, remained
robust. If parameter estimates of the Weibull models are transformed to haz-
ard ratios, every U.S.$100 less spent is associated with a 0.64 percent increase
in the hazard of dying and a 1.27 percent increase in the hazard of a read-
mission conditional on not dying.
1596 HSR: Health Services Research 45:6, Part I (December 2010)DISCUSSION
In this paper, we investigated and we quantiﬁed the relationship between
hospital costs and health outcomes for patients with AMI using a two-step
random intercept Cox proportional hazard model to obtain consistent
estimates of the effects of costs on outcomes. We followed a more reﬁned
approach than previous studies investigating this relationship by (a) focusing
on one episode of care, (b) using patient-level data, and (c) applying a survival
model.Ourresultsarealsoclearerthanthatofpreviousstudies.Wefoundthat
costs were negatively associated with mortality and with readmission condi-
tional on not dying. Thus, the cost–outcome relationship appears to be very
clear in both cases, although costs were more signiﬁcant in the readmission
equation compared with the mortality equation.
The ﬁnding that the relationship between costs and outcomes is neg-
atively correlated for both outcome measures is at odds with the results ob-
tained by Carey and Burgess (1999), who also based their analysis on VHA
data. They found that both 1-year mortality and 1-year readmissions were
positively associated with hospital costs. They suggested that differences in
severity of illness unmeasured by the case mix were a likely explanation for
this result. However, comparability to our study is limited by the fact that
CareyandBurgess(1999)didnotconcentratesolelyonAMIasoneepisodeof
care and by that they used aggregate hospital costs instead of patient-level
costs. In addition, they did not use a survival model and did not control for
competingrisks.Ingeneral,noneofthepreviousstudiesusedasurvivalmodel
toinvestigatethecost–outcomerelationship,makinganycomparisonwithour
study difﬁcult.
The negative association between costs and the risk for mortality/read-
mission conditional on not dying conﬁrms the often-stated hypothesis that
increased resource input for patients should clearly lead to better outcomes.
Some of the hospital-level variables had unexpected signs, although most of
them (e.g., COTH) were not signiﬁcant. However, the positive coefﬁcient for
the variable for capability of angiography in both equations suggests that the
risk for an event, that is, readmission conditional on not dying or death,
increases signiﬁcantly with capability of angiography. One potential expla-
nation for this pattern may be that certain measures for case mix are not
included.Thus,thepositivecoefﬁcientsforangiographycapabilitymayreﬂect
higher severity rather than input quality.
Ourstudyhasanumberofstrengths.Tobeginwith,itistheﬁrststudy,to
our knowledge, to examine the trade-off between costs and outcomes using
The Trade-Off between Costs and Outcomes 1597patient-levelcostandoutcomedata.Theuseofpatient-leveldataenabledusto
obtain more consistent estimates on the relationship between costs and out-
comes. Second, we focused on AMI as one episode of care, which allowed us
to control appropriately for case mix. Third, we are the ﬁrst study exploring
this trade-off using a Cox proportional hazard model and considering the
competing risk nature of the data. Fourth, the rich data sample containing
information at the patient and hospital levels allowed us to use a multilevel
model combined with a 2SRI model. This is likely to yield more consistent
estimates than conventional statistical methods.
Our study also has several important limitations. First, certain undoc-
umented health-related conditions or factors may explain part of the variation
in our outcome variables, thus potentially affecting the relationship between
costs and outcomes. Also, the validity of the instruments relies on the as-
sumption that the error structure follows a random effects model. Another
limitation may be this study’s focus on mortality and readmissions as opposed
to clinical-outcome measures.
Although the VHA has a standardized internal accounting system, cer-
tain variations in costs may be explained by the different accounting systems
used in different VHA hospitals, which is a factor we were unable to control
for. Finally, our study uses only VHA data, which raises the question of gen-
eralizability beyond the VHA. It is likely that the relationship between costs
and outcomes varies according to the health care context, differing, for ex-
ample, between fragmented and integrated health care systems. For instance,
an integrated delivery system with managed care elements, such as the VHA,
is more likely than fragmented health care systems to avoid or substitute
readmissions. Thus, in the VHA context, it is conceivable that patients with
multiple conditions——for which acute hospital treatment was not appropri-
ate——were less likely to be readmitted.
In spite of the clear ﬁndings, care must be taken when drawing policy
implications. Certainly, the negative association between costs and mortality
and costs and readmission conditional on not dying does not mean that every
clinical intervention is justiﬁed, especially if the costs of the intervention are
greater than the beneﬁts. However, this negative association does suggest that
reductions in costs may indeed lead to poorer outcomes. Because of this,
outcomes should be monitored closely when introducing cost-containment
programs.Moreover,linkingreimbursementratestooutcomes,asispracticed
in reimbursement programs such as ‘‘Pay for Performance’’ in the United
States or ‘‘Payment by Results’’ in the United Kingdom, might represent a
promising approachto overcoming thetrade-off between costs and outcomes,
1598 HSR: Health Services Research 45:6, Part I (December 2010)supplying providers with incentives to keep outcomes stable in spite of
decreasing costs.
Research on the relationship between costs and outcomes is still in its
infancy. Additional studies are needed to examine the cost–outcome rela-
tionship for conditions other than AMI to see whether our results are
consistent. With this in mind, examining the various treatment processes
within organizations would also seem a fruitful way of gaining a greater un-
derstanding of this relationship.
ACKNOWLEDGMENTS
Joint Acknowledgment/Disclosure Statement: Jonas Schreyo ¨gg was supported by
the Commonwealth Fund Harkness Fellowship in Healthcare Policy for the
academic year 2006/2007 at Stanford University. We are also indebted to
Alan Garber for helpful comments.
Disclosures: None.
Disclaimers: None.
REFERENCES
Allison, P. D. 2005. Survival Analysis Using SAS, a Practical Guide. Cary, NC: SAS
Institute Inc.
Bartels,L.1991.‘‘Instrumentaland‘Quasi-Instrumental’Variables.’’AmericanJournalof
Political Science 35: 777–800.
Birkmeyer,J.,A. Siewers, E.Finlayson,T.Stukel,F.Lucas, I.Batista, H.Welch,andD.
Wennberg. 2002. ‘‘Hospital Volume and Surgical Mortality in the United
States.’’ New England Journal of Medicine 346: 1128–37.
Bound, J., D. Jaeger, and R. Baker. 1995. ‘‘Problems with Instrumental Variables Es-
timation When the Correlation between the Instruments and the Endogenous Ex-
planatory Variable Is Weak.’’ Journal of American Statistical Association 90: 443–50.
Cameron, A. C., and P. K. Trivedi. 2005. Microeconometrics: Methods and Applications.
New York: Cambridge University Press.
Carey, K., and J. Burgess. 1999. ‘‘On Measuring the Hospital Cost/Quality Trade-off.’’
Health Economics 8: 509–20.
Deily, M., and N. McKay. 2006. ‘‘Cost Inefﬁciency and Mortality Rates in Florida
Hospitals.’’ Health Economics 15: 419–31.
Dudley, R., K. Johansen, R. Brand, D. Rennie, and A. Milstein. 2000. ‘‘Selective
Referral to High-Volume Hospitals.’’ Journal of American Medical Association 283:
1159–66.
The Trade-Off between Costs and Outcomes 1599Evans, E., Y. Imanaka, M. Sekimoto, T. Ishizaki, K. Hayashida, H. Fukuda, and E. H.
Oh. 2007. ‘‘Risk Adjusted Resource Utilization for AMI Patients Treated in
Japanese Hospitals.’’ Health Economics 16: 347–59.
Fleming, S. T. 1991. ‘‘The Relationship between Quality and Cost: Pure and Simple?’’
Inquiry 28 (1): 29–38.
Glidden, D. V., and E. Vittinghoff. 2004. ‘‘Modelling Clustered Survival Data from
Multicentre Clinical Trials.’’ Statistics in Medicine 23: 369–88.
Grambsch, P. M., and T. M. Therneau. 1994. ‘‘Proportional Hazard Tests and Diag-
nostics Based on Weighted Residuals.’’ Biometrika 81: 515–26.
Grannemann, T. W., R. S. Brown, and M. V. Pauly. 1986. ‘‘Estimating Hospital Costs:
A Multiple-Output Analysis.’’ Journal of Health Economics 5: 107–27.
Hausman, J.A. 1978. ‘‘Speciﬁcation Tests in Econometrics.’’Econometrica46:1251–71.
Kovner, C., C. Jones, C. Zhan, P. Gergen, and J. Basu. 2002. ‘‘Nurse Stafﬁng
and Postsurgical Adverse Events: An Analysis of Administrative Data
from a Sample of U.S. Hospitals, 1990–1996.’’ Health Services Research 37:
611–27.
Landrum, M. B., E. Guadagnoli, R. Zummo, D. Chin, and B. J. McNeil. 2004. ‘‘Care
Following Acute Myocardial Infarction in the Veterans Administration Medical
Centers: A Comparison with Medicare.’’ Health Services Research 39: 1773–92.
Lindrooth, R. C., and B. A. Weisbrod. 2007. ‘‘Do Religious Non-Proﬁt and For-Proﬁt
Organizations Respond Differently to Financial Incentives?’’ Journal of Health
Economics 26: 342–57.
McClellan, M., and D. Staiger. 2000. ‘‘Comparing the Quality of Health Care
Providers.’’ In Frontiers in Health Policy Research, Vol. 3, edited by A. Garber,
pp. 113–36. Cambridge, MA: MIT Press.
McKay, N. L., and M. E. Deily. 2008. ‘‘Cost Inefﬁciency and Hospital Health Out-
comes.’’ Health Economics 17: 833–48.
Morey, R., D. Fine, S. Loree, D. Retzlaff-Roberts, and S. Tsubakitani. 1992. ‘‘The
Trade-Off between Hospital Cost and Quality of Care: An Exploratory Empir-
ical Analysis.’’ Medical Care 30: 677–98.
Mukamel, D. B., J. Zwanziger, and K. J. Tomaszewski. 2001. ‘‘HMO Penetration,
Competition, and Risk-Adjusted Hospital Mortality.’’ Health Services Research 36
(6): 1019–35.
Murphy, K. M., and R. H. Topel. 1985. ‘‘Estimation and Inference in Two-Step
Econometric Models.’’ Journal of Business and Economic Statistics 3: 88–97.
Needleman, J., P. Buerhaus, S. Mattke, and M. Stewart. 2002. ‘‘Nurse-Stafﬁng Levels
and the Quality of Care in Hospitals.’’ New England Journal of Medicine 346:
1715–22.
Sa ´, C.,C.E. Dismuke, andP.Guimaras.2007.‘‘SurvivalAnalysis andCompetingRisk
Models of Hospital Length of Stay and Discharge Destination: The Effect
of Distributional Assumptions.’’ Health Services Outcomes Research Methodology 7:
109–24.
Shen, Y. C. 2002. ‘‘The Effects of Hospital Ownership Choice on Patient Outcomes
after Treatment for Acute Myocardial Infarction.’’ Journal of Health Economics 21:
901–22.
1600 HSR: Health Services Research 45:6, Part I (December 2010)Staiger, D., J. H. Stock. 1994. ‘‘Instrumental Variables Regression with Weak
Instruments.’’ NBER Technical Working Papers 0151, National Bureau of
Economic Research, Inc.
Sundararajan, S., T. Henderson, C. Perry, A. Muggivan, H. Quan, and W. A. Ghali.
2004. ‘‘New ICD-10 Version of the Charlson Comorbidity Index Predicted In-
Hospital Mortality.’’ Journal of Clinical Epidemiology 57: 1288–94.
Terza, J. V., A. Basu, and P. J. Rathouz. 2008. ‘‘Two-Stage Residual Inclusion Esti-
mation: Addressing Endogeneity in Health Econometric Modeling.’’ Journal of
Health Economics 27: 531–43.
Thompson, L., R. Chhikara, and J. Conkin. 2003. Cox Proportional Hazards Models for
Modeling the Time to Onset of Decompression Sickness. NASA Technical Publication
2003-210791. Houston, TX: Johnson Space Center.
Tu, J. V., P. C. Austin, R. Walld, L. Roos, J. Agras, and K. M. McDonald. 2001.
‘‘Development and Validation of the Ontario Acute Myocardial Infarction Mor-
tality Prediction Rules.’’ Journal of the American College of Cardiology 37: 992–97.
Weech-Maldonado, R., D. Shea, and V. Mor. 2006. ‘‘The Relationship between Qual-
ity of Care and Costs in Nursing Homes.’’ American Journal of Medical Quality 21:
40–8.
Yaisawarng, S., and J. F. Burgess. 2006. ‘‘Performance-Based Budgeting in the Public
Sector: An Illustration from the VA Health Care System.’’ Health Economics 15:
295–310.
Yamaguchi, T., Y. Ohashi, and Y. Matsuyama. 2002. ‘‘Proportional Hazards Model
with Random Effects to Examine Centre Effects in Multicentre Cancer Clinical
Trials.’’ Statistical Methods in Medical Research 11: 221–36.
SUPPORTING INFORMATION
Additional supporting information may be found in the online version
of this article:
Appendix SA1: Author Matrix.
Please note: Wiley-Blackwell is not responsible for the content or func-
tionality of any supporting materials supplied by the authors. Any queries
(other than missing material) should be directed to the corresponding author
for the article.
The Trade-Off between Costs and Outcomes 1601